Pharmaceutical Business review

Encorium secures $3.4 million in business contracts

The therapeutic areas included in these awards are oncology, gynecology, respiratory diseases, and gastroenterology. Services to be provided include project management, field monitoring, data management, statistics, medical writing, and quality assurance. Revenue recognition will occur on a proportional performance basis as services are performed on each project.

Kenneth Borow, president and CEO for Encorium Group, said: “In the past two weeks Encorium has announced $7.1 million of new business awards. These have been over a wide array of therapeutic areas and have included many different services that will be provided to our clients. The work associated with these opportunities will be performed on a multinational basis.”